1,721,003 research outputs found
sj-docx-1-msj-10.1177_13524585221136036 – Supplemental material for External validation of a clinical prediction model in multiple sclerosis
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585221136036 for External validation of a clinical prediction model in multiple sclerosis by Nahid Moradi, Sifat Sharmin, Charles B Malpas, Vahid Shaygannejad, Murat Terzi, Cavit Boz, Bassem Yamout, Samia J Khoury, Recai Turkoglu, Rana Karabudak, Nevin Shalaby, Aysun Soysal, Ayşe Altıntaş, Jihad Inshasi, Talal Al-Harbi, Raed Alroughani and Tomas Kalincik in Multiple Sclerosis Journal</p
Supplemental material for Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study
No full textSupplemental Material for Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study by Lisanne J Balk, Danko Coric Benjamin Knier Hanna G Zimmermann Raed Behbehani Raed Alroughani Elena H Martinez-Lapiscina Alexander U Brandt Bernardo Sánchez-Dalmau Angela Vidal-Jordana Philipp Albrecht, Valeria Koska, Joachim Havla Marco Pisa Rachel C Nolan Letizia LeocaniFriedemann Paul, Orhan Xavier Montalban Aktas , Laura J Balcer Pablo Villoslada Olivier OutteryckThomas Korn, Axel Petzold and on behalf of the IMSVISUAL consortium in Multiple Sclerosis Journal – Experimental, Translational and Clinical</p
MSJ888610_supplementary_material – Supplemental material for Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies
No full textSupplemental material, MSJ888610_supplementary_material for Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies by Giancarlo Comi, Raed Alroughani, Aaron L Boster, Ann D Bass, Regina Berkovich, Óscar Fernández, Ho Jin Kim, Volker Limmroth, Jan Lycke, Richard AL Macdonell, Basil Sharrack, Barry A Singer, Patrick Vermersch, Heinz Wiendl, Tjalf Ziemssen, Alan Jacobs, Nadia Daizadeh, Claudio E Rodriguez and Anthony Traboulsee in Multiple Sclerosis Journal</p
sj-docx-1-tan-10.1177_17562864231221331 – Supplemental material for Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies
No full textSupplemental material, sj-docx-1-tan-10.1177_17562864231221331 for Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapies by Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan and Tim Spelman in Therapeutic Advances in Neurological Disorders</p
Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence
No full textArticle full text
The full text of this article can
be found here. https://link.springer.com/article/10.1007/s40120-017-0080-x
Provide enhanced content for this
article
If you are an author of this
publication and would like to provide additional enhanced content for your
article then please contact [email protected].
The journal offers a range of
additional features designed to increase visibility and readership. All
features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.
Other enhanced features include,
but are not limited to:
• Slide decks
• Videos and animations
• Audio abstracts
• Audio slides</p
Additional file 2 of A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
No full textAdditional file 2. Questionnaire for Contro
Additional file 1 of A matched case-control study of risk factors associated with multiple sclerosis in Kuwait
No full textAdditional file 1. Questionnaire for Cas
MSJ881994__Appendix_2 – Supplemental material for Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype
No full textSupplemental material, MSJ881994__Appendix_2 for Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype by Yuan Zhou, Suzi B Claflin, Jim Stankovich, Ingrid van der Mei, Steve Simpson, Richard H Roxburgh, Tomas Kalincik, Leigh Blizzard, Alessandra Lugaresi, Raed Alroughani, Seyed Aidin Sajedi, Helmut Butzkueven, Eugenio Pucci, Daniele LA Spitaleri, Franco Granella, Edgardo Cristiano, Bassem Yamout, Stella Hughes, Riadh Gouider, José Luis Sánchez Menoyo, Javier Olascoaga, Chris McGuigan, Cameron Shaw, Allan G Kermode, Krisztian Kasa, Talal Al-Harbi, Ayse Altintas, Guy Laureys, Yara Fragoso, Todd A Hardy, Tunde Csepany, Carmen-Adella Sirbu, Danny Decoo, Attila Sas, Jose C Alvarez-Cermeño, Karim Kotkata, Jorge Millán-Pascual and Bruce V Taylor in Multiple Sclerosis Journal</p
MSJ881994_supplementary_material – Supplemental material for Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype
No full textSupplemental material, MSJ881994_supplementary_material for Redefining the Multiple Sclerosis Severity Score (MSSS): The effect of sex and onset phenotype by Yuan Zhou, Suzi B Claflin, Jim Stankovich, Ingrid van der Mei, Steve Simpson, Richard H Roxburgh, Tomas Kalincik, Leigh Blizzard, Alessandra Lugaresi, Raed Alroughani, Seyed Aidin Sajedi, Helmut Butzkueven, Eugenio Pucci, Daniele LA Spitaleri, Franco Granella, Edgardo Cristiano, Bassem Yamout, Stella Hughes, Riadh Gouider, José Luis Sánchez Menoyo, Javier Olascoaga, Chris McGuigan, Cameron Shaw, Allan G Kermode, Krisztian Kasa, Talal Al-Harbi, Ayse Altintas, Guy Laureys, Yara Fragoso, Todd A Hardy, Tunde Csepany, Carmen-Adella Sirbu, Danny Decoo, Attila Sas, Jose C Alvarez-Cermeño, Karim Kotkata, Jorge Millán-Pascual and Bruce V Taylor in Multiple Sclerosis Journal</p
sj-docx-1-msj-10.1177_13524585221084577 – Supplemental material for Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS
No full textSupplemental material, sj-docx-1-msj-10.1177_13524585221084577 for Multiple Sclerosis Severity Score (MSSS) improves the accuracy of individualized prediction in MS by Tomas Kalincik, Ilya Kister, Tamar E Bacon, Charles B Malpas, Sifat Sharmin, Dana Horakova, Eva Kubala-Havrdova, Francesco Patti, Guillermo Izquierdo, Sara Eichau, Serkan Ozakbas, Marco Onofrj, Alessandra Lugaresi, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Patrizia Sola, Diana Ferraro, Raed Alroughani, Murat Terzi, Cavit Boz, Francois Grand’Maison, Roberto Bergamaschi, Oliver Gerlach, Maria J Sa, Ludwig Kappos, Elisabetta Cartechini, Jeannette Lechner-Scott, Vincent van Pesch, Vahid Shaygannejad, Franco Granella, Daniele Spitaleri, Gerardo Iuliano, Davide Maimone, Julie Prevost, Aysun Soysal, Recai Turkoglu, Radek Ampapa, Helmut Butzkueven and Gary Cutter in Multiple Sclerosis Journal</p
- …
